Bracco

Home

Bracco
305 College Rd E
Princeton
NJ 08540
Tel: + 39 02 2177.2469
contact: info@bracco.com
website: www.bracco.com
The Bracco Group
Bracco, ruled by President Diana Bracco, is an international Group active in the healthcare sector through Bracco Imaging (diagnostic imaging), Pharma (prescription and over the counter drugs), Acist (advanced injection systems based in Minneapolis), and the Centro Diagnostico Italiano diagnostic clinic in Milan. It has 2,800 employees and annual total consolidated revenues of approximately 900 million euro, of which 60% from international sales and it operates in over 80 markets worldwide, either directly or indirectly through subsidiaries, joint ventures, license and distribution partnership agreements.

Originally established as a pharmaceuticals company in 1927, over the years Bracco has intensified its commitment to innovative specialist research in imaging agents for diagnostic medicine. A key breakthrough came in the 1970s with the development of the iopamidol molecule, the first ready-to-use non-ionic contrast agent. In the wake of this success, at the end of the 1980s the Group launched a program for international expansion, notably in the USA, now Bracco Imaging’s primary market. Here, the Group operates through Bracco Diagnostics Inc. and Bracco Research USA, both based in Princeton, New Jersey, where its worldwide clinical development work is coordinated. Bracco has also established itself as a major player in Japan, Europe and China, where it has a factory and laboratories in Shanghai, and a sales office and clinical development labs in Beijing.

Its subsidiary Bracco Imaging is one of the world's leading companies in the diagnostic imaging, offering a product and solutions portfolio for the main applications (X-Rays, Magnetic Resonance, Ultrasound, Nuclear Medicine). The recent acquisition of E-Z-EM Inc, a major manufacturer of contrast agent and medical instruments for gastrointestinal radiology, has further increased Bracco Imaging's offer. With its three Research Centers, in Ivrea (Turin), Geneva and Princeton (New Jersey), Bracco has an international research network specialized in the imaging field. The company invests approximately 11% of reference turnover in its R&D work every year and has a portfolio comprising over 1500 patents.

The Bracco diagnostic imaging offer is completed by Advanced Contrast Imaging System Technology in the fields of cardiology and radiology developed by Acist, a leading-edge company in contrast delivery systems. The company, which was acquired by the Bracco Group in 2001, has its corporate headquarters in Eden Prairie, Minnesota, with regional offices in Europe and Asia. Today it employs over 220 people worldwide and its advanced systems are used in over 40 countries in the most world-renowned centers. More than 4.5 million people around the world have had cardiovascular angiographic procedures using an ACIST system.

In Italy, through the Pharmaceuticals Division, Bracco Spa is a key player in many strategically important therapeutic fields, including gastroenterology, neurology, endocrinology and cardio-vascular pathology, where it markets own-brand drugs or pharmaceuticals under license. The Pharmaceutical Division is present in the territory through a network of 240 pharmaceutical representatives, supported by a diffused sales organization.

The Bracco brand is widely known in Italy for its over-the-counter products, both farmaceutical and dietetics. The product range includes Cebion, Xamamina, Euclorina and the Alfa eye-drops product line.

Another important area of activity of the Bracco Group regards the healthcare services provided by the Centro Diagnostico Italiano, a polyclinic based in Milan, with 13 satellite units in the city and in Lombardy, which offers different services of prevention, diagnosis and personalized treatment. With a 30 years experience, it offers a wide range of prevention, diagnosis and therapy services on day-surgery basis for an amount per year of 110.000 diagnostic procedures in 50 clinical specializations and 3,5 million analysis for 500 types of exams. Equipped with the very latest technological systems (such as the Cyberknife radiosurgery robot), the CDI is an accredited body of the Joint Commission International.
Related categories: Pharmaceutical Companies

Pharma Division

Development, manufacturing and distribution of pharmaceutical and nutraceutical products ONLY IN ITALY.

The Bracco Pharmaceuticals Division accounts for about one fifth of Group revenues and ranks among the leading operators in the Italian industry.

It includes many own-brand prescription drugs and products produced under license from top international partners. Its popular over-the-counter products, pharmaceuticals and dietary products have made it a household name.

To have more information on products, please visit the Italian site section.
The company distributes these pharmaceuticals exclusively in Italy. The range of products includes self-medication (over-the-counter pharmaceutical brands, dietary products, dietary sport supplements, cosmetics) that can be purchased in pharmacies without prescriptions.

If you are an healthcare professional and you need more information on products, please visit the Italian site section.
Bracco's line of physician-prescribed branded pharmaceuticals plays a leading role among the top 20 pharmaceutical firms and is present exclusively in Italy. The company's brands are present in the most advanced and fast-developing sector:
  • gastroenterology for the treatment of ulcers, gastritis, and inflammatory intestinal diseases
  • gynecology in particular for hormone replacement therapy, the prevention of osteoporosis, and a lack of folic acid
  • neurology/psychiatry for Alzheimer's Disease therapy and depression
  • antibiotic therapy with antitubercular preparations included in the list of the World Health Organization, and for the cure of urogenital and respiratory infections
  • cardiology with an antihypertension beta inhibitor
  • metabolic area with thyroid and synthetic hormones.
For the best use of these branded pharmaceuticals, and in order to follow the new scientific guidelines and foresee future applications and tendencies, a special structure has been set up that keeps in constant contact with the various fields of specialized medicine.
If you are an healthcare professional and you need more information on products, please visit the Italian site section.
Copyright® 2010 Business Briefings, Ltd. All rights reserved.
Touch Gastroenterology is for informational purposes and should not be considered medical advice, diagnosis or treatment recommendations.